<DOC>
	<DOCNO>NCT01337466</DOCNO>
	<brief_summary>This protocol evaluate biodistribution dosimetry [ 124I ] FIAU healthy volunteer patient prosthetic joint infection . This pilot study also investigate safety tolerability [ 124I ] FIAU .</brief_summary>
	<brief_title>Biodistribution Dosimetry Evaluation 124IFIAU</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Prosthesis-Related Infections</mesh_term>
	<mesh_term>Fialuridine</mesh_term>
	<criteria>The following main inclusion criterion subject : 1 . Males females age &gt; 18 year 2 . Informed consent 3 . Subjects chronic medical condition hypertension diabetes consider stable principal investigator 4 . Women postmenopausal surgically sterile 5 . Able return study assessment In addition , follow main inclusion criterion apply subject suspect prosthetic joint infection : 1 . Operative intervention plan 30 day follow study enrollment 2 . Prosthetic joint implant site 3 month prior enrollment The following main exclusion criterion subject : 1 . Unable comply study requirement 2 . Indication opinion principal investigator surgery within 48 hour presentation . 3 . Receipt antibiotic therapy 2 week precede image 4 . Immunosuppression , e.g. , human immunodeficiency virus ( HIV ) infection , s/p organ transplantation , receipt steroid &gt; 10 day &gt; 10 mg prednisone equivalent daily within 90 day prior enrollment 5 . Requirement medication predispose lactic acidosis ( e.g. , metformin , iron , isoniazid salicylate ; see Appendix A ) 6 . Requirement medication potential mitochondrial toxicity , e.g. , nucleoside analogue ( zidovudine , didanosine , stavudine ) 7 . History inherited mitochondrial disorder ( e.g. , Leber 's hereditary neuropathy , neuropathy , ataxia , retinitis pigmentosa ptosis [ NARP ] , myoneurogenic gastrointestinal encephalopathy [ MNGIE ] , myoclonic epilepsy rag red fiber [ MERFF ] mitochondrial myopathy , encephalomyopathy , lactic acidosis strokelike syndrome [ MELAS ] 8 . Chronic hepatitis B virus ( HBV ) hepatitis C virus ( HCV ) infection 9 . Preexisting myopathy neuropathy 10 . Abnormal liver function test define alanine aminotransferase ( ALT ) &gt; upper limit normal ( ULN ) , aspartate aminotransferase ( AST ) &gt; ULN , gamma glutamyl transferase ( GGT ) &gt; ULN 11 . Alcohol use &gt; 3 unit per day men 2 unit per day woman active intravenous drug use 12 . Creatinine clearance &lt; 30 mL/min 13 . Body mass index &gt; 40 14 . Life expectancy &lt; 6 month 15 . Hypersensitivity iodine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Phase I</keyword>
	<keyword>FIAU</keyword>
	<keyword>Fialuridine</keyword>
	<keyword>Biodistribution</keyword>
	<keyword>Dosimetry</keyword>
	<keyword>Prosthetic</keyword>
	<keyword>Joint</keyword>
	<keyword>Infection</keyword>
	<keyword>PET-CT</keyword>
</DOC>